Literature DB >> 9238931

Patients' experiences of chemotherapy: side-effects of carboplatin in the treatment of carcinoma of the ovary.

R Buckingham1, J Fitt, J Sitzia.   

Abstract

There has been little investigation of the side-effects experienced by women receiving adjuvant carboplatin in the treatment of ovarian cancer. This study aimed to describe the range of problems experienced by patients and to estimate incidence and severity of side-effects over the treatment period. Eleven patients participated and completed a 75-item self-report questionnaire at each course of treatment. Severity of each side-effect was graded from 0 to 4. Patients also stated which had been the worst side effect at each course. The response rate was 94%. Seventy-two side-effects were reported. Fatigue emerged as both the most common and the most 'troublesome' side-effect. Nausea, difficulty sleeping, taste change, and constipation were also ranked highly. Although limited by a small sample size, this study suggests patients undergoing carboplatin experience a wide range of problems, many of which merit further investigation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9238931     DOI: 10.1111/j.1365-2354.1997.tb00270.x

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  5 in total

1.  Lipid replacement/antioxidant therapy as an adjunct supplement to reduce the adverse effects of cancer therapy and restore mitochondrial function.

Authors:  Garth L Nicolson
Journal:  Pathol Oncol Res       Date:  2005-09-29       Impact factor: 3.201

2.  Patient reporting of potential adverse drug reactions: a methodological study.

Authors:  N Jarernsiripornkul; J Krska; P A G Capps; R M E Richards; A Lee
Journal:  Br J Clin Pharmacol       Date:  2002-03       Impact factor: 4.335

3.  Novel drug isolated from mistletoe (1E,4E)-1,7-bis(4-hydroxyphenyl)hepta-1,4-dien-3-one for potential treatment of various cancers: synthesis, pharmacokinetics and pharmacodynamics.

Authors:  Jing Hong; Lin Meng; Peipei Yu; Ceng Zhou; Zhaoyan Zhang; Zhiguo Yu; Feng Qin; Yunli Zhao
Journal:  RSC Adv       Date:  2020-07-24       Impact factor: 4.036

Review 4.  Reversing mitochondrial dysfunction, fatigue and the adverse effects of chemotherapy of metastatic disease by molecular replacement therapy.

Authors:  Garth L Nicolson; Kenneth A Conklin
Journal:  Clin Exp Metastasis       Date:  2007-12-05       Impact factor: 5.150

5.  Comparison of the therapeutic effects of lobaplatin and carboplatin on retinoblastoma in vitro and in vivo.

Authors:  Zijun Zhou; Hua Jiang; Jiejun Xia; Jing Zhang
Journal:  Int J Oncol       Date:  2020-06-22       Impact factor: 5.650

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.